Overexpression of the transcriptional coactivator peroxisome proliferator-activated receptor ␥ coactivator 1␣ (PGC-1␣), like exercise, increases mitochondrial content and inhibits muscle atrophy. To understand these actions, we tested whether PGC-1␣ or its close homolog, PGC-1, influences muscle protein turnover. In myotubes, overexpression of either coactivator increased protein content by decreasing overall protein degradation without altering protein synthesis rates. Elevated PGC-1␣ or PGC-1 also prevented the acceleration of proteolysis induced by starvation or FoxO transcription factors and prevented the induction of autophagy and atrophy-specific ubiquitin ligases by a constitutively active FoxO3. In mouse muscles, overexpression of PGC-1 (like PGC-1␣) inhibited denervation atrophy, ubiquitin ligase induction, and transcription by NFB. However, increasing muscle PGC-1␣ levels pharmacologically by treatment of mice with 5-aminoimidazole-4-carboxamide 1--D-ribofuranoside failed to block loss of muscle mass or induction of ubiquitin ligases upon denervation atrophy, although it prevented loss of mitochondria. This capacity of PGC-1␣ and PGC-1 to inhibit FoxO3 and NFB actions and proteolysis helps explain how exercise prevents muscle atrophy.The mass of a muscle and its functional capacity are determined by the balance between rates of protein synthesis and protein degradation. The rapid, debilitating loss of muscle that occurs upon inactivity, nerve damage, and in many systemic diseases (e.g. diabetes, cancer, sepsis, or renal failure) is characterized by an increased rate of protein degradation (1, 2) and coordinated changes in the expression of a set of atrophy-related genes, which have been termed "atrogenes" (3, 4). Many of these genes are induced by the FoxO family of transcription factors (5, 6), which is activated in atrophying muscles. In fact, activated FoxO3 alone stimulates overall protein degradation by both the ubiquitin-proteasome and the autophagic-lysosomal systems (7,8) and induces fiber atrophy (5). Two FoxOinduced genes are particularly important in enhancing proteolysis, the muscle-specific ubiquitin ligases, Atrogin1/MAFBx and MuRF1 (5, 9, 10), and muscles that lack either of these ligases show reduced fiber atrophy upon denervation (9). Another transcription factor that plays an essential role in muscle atrophy is NFB. Although activation of the NFB pathway is sufficient to induce muscle wasting (11, 12), its precise role and the factors that control its activity in muscle are still poorly understood.Despite appreciable recent progress in understanding the biochemical basis of atrophy, no pharmaceutical agents are available to inhibit this highly debilitating process. Exercise can protect against disuse atrophy as well as various systemic types of muscle wasting (13-15), but the mechanisms by which contractile activity reduces atrophy remain unclear. In principle, contractile activity may somehow enhance protein synthesis, suppress overall protein breakdown, and/or block the atrophy...